Results 161 to 170 of about 9,098,363 (304)
A model-based design strategy to engineer miRNA-regulated detection systems. [PDF]
Verkuijlen RJ, Smith RW.
europepmc +1 more source
Model-Based Design of Long-Distance Tracer Transport Experiments in Plants. [PDF]
Bühler J, von Lieres E, Huber GJ.
europepmc +1 more source
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Seamless monotherapy-combination phase I dose-escalation model-based design. [PDF]
Daniells L +6 more
europepmc +1 more source
Implementation of a Model-Based Design in a Phase Ib Study of Combined Targeted Agents. [PDF]
Wages NA +4 more
europepmc +1 more source
Model-based User Interface Design
This work is about supporting user interface design by means of explicit design representations, in particular models. We take as a starting point two different development traditions: the formal, analytic, topdown engineering approach and the informal, synthetic, bottom-up designer approach.
openaire +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Enabling Model-Based Design for Real-Time Spike Detection. [PDF]
Di Florio M +5 more
europepmc +1 more source
Tumor mutational burden as a determinant of metastatic dissemination patterns
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Model-based design of a mechanically intelligent shape-morphing structure. [PDF]
Chen Q, Schott D, Jovanova J.
europepmc +1 more source

